Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate. - Wikidata - wikimedia - TriplyDB

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

http://www.wikidata.org/entity/Q35168298

about

A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study Autocrine effects of interleukin-6 mediate acute-phase proinflammatory and tissue-reparative transcriptional responses of canine bladder mucosa Models of inflammation of the lower urinary tract.Impaired Expression of Prostaglandin E2 (PGE2) Synthesis and Degradation Enzymes during Differentiation of Immortalized Urothelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome.Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.Intravesical Glycosaminoglycan Replacement with Chondroitin Sulphate (Gepan(®) instill) in Patients with Chronic Radiotherapy- or Chemotherapy-Associated Cystitis Increased bladder permeability in interstitial cystitis/painful bladder syndrome.In the absence of overt urothelial damage, chondroitinase ABC digestion of the GAG layer increases bladder permeability in ovariectomized female rats GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans--a review.Intravesical treatments of bladder pain syndrome/interstitial cystitis.Intravesical drug delivery for dysfunctional bladder.Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations.Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro.Reduction of intercellular adhesion molecule 1 may play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis.Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury.Establishment of a Novel Autoimmune Experimental Model of Bladder Pain Syndrome/Interstitial Cystitis in C57BL/6 Mice.How are we going to make progress treating bladder pain syndrome? ICI-RS 2013.

P2860

Q34298261-B6CEE61E-9D89-4FDC-AF55-F0E0491D7C88 Q34529396-B61CE228-B9FA-41AE-BE3D-B426549A41E0 Q35041139-032CFA55-E76D-4A52-A0FB-2EF5B0BF77B0 Q35658420-99A4B2B1-7E82-4E5F-B968-D22642ABED5C Q35742694-97C20E65-3801-4617-B3F7-D3A22BE1395D Q35901614-10C8248E-9F5A-4562-B54A-B66E77B64517 Q36445359-3896B971-C4F9-4584-9ABA-C4D35F422D85 Q37211821-C34B29D3-059E-4062-828B-8BAC044A80ED Q38025374-6ADBCC91-E8F1-406E-ACED-D928FA7051B0 Q38062822-814A841C-12B7-443E-A130-8712D0CCB3E3 Q38075592-B75A0585-0A25-48AB-BCD2-E1868D6ADBCD Q38196864-972A0445-4699-44A8-8DDC-C376DA89D097 Q38759710-2A25644A-7267-43D3-9C7E-A4E5D360EC2E Q42039790-4916BEA5-0EDA-403C-BE8D-4FD48C65C345 Q46767552-25C3A879-B100-475F-9DF4-565EED3E0A89 Q52680751-CB95B335-7ABA-499F-AFAC-7F1569D3B26D Q52902261-4F793C12-0A8C-445A-8235-2585EDC6B258 Q53093747-B2E39621-D483-42FA-9866-A6FB1D7BF7D5

P2860

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

http://www.wikidata.org/entity/Q35168298

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

@ast

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

@en

type

label

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

@ast

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

@en

prefLabel

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

@ast

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

@en

P1433

Q35168298-E6BF36A2-864B-48C4-9D52-989159516CBC

P1476

Q35168298-D686B35E-027A-42F6-9A0B-C89D3FDF71D9

P2093

Q35168298-18C705F2-5561-4EF0-A604-5217BBBC5AD7

Q35168298-52491C45-B1EC-4C96-BEFB-BE6FE9D87DB2

Q35168298-6727216C-7A0B-41FE-B195-FFA2CF491C9D

Q35168298-BDB85A63-34CE-4801-A3CB-C644E3CB6472

Q35168298-EEECA3BF-AB68-446A-888B-F6A95E7F444D

P2860

Q35168298-16064D25-AC2F-42A1-9091-730E7146C709

Q35168298-4A8787E2-80C7-4A7E-A1D1-1D864944F39F

Q35168298-628CEBE1-4E39-40AD-BF7B-3AFB91644A9D

Q35168298-6AC5D156-8591-4552-9E7D-0E8B7A334E24

Q35168298-6DBBEE3E-6323-4E3E-93DF-A87A66F4A840

Q35168298-7B8A2AF2-A45B-40BF-9942-5112823AC8D6

Q35168298-9314F3CE-E10D-4A7C-8E89-643793DDBB55

Q35168298-96953787-B788-42AA-8C22-CE8A114CC402

Q35168298-9FC80B4C-DE8E-4E21-8587-5A2E20B53629

Q35168298-AA8D6346-8C5C-484B-B835-9C2AE95E9FDC

P304

Q35168298-236E587A-067B-43D5-A427-A2B03E78D6D0

P31

Q35168298-CB5422F4-9C14-4A3A-BE00-E9389386A629

P356

Q35168298-4E38E902-49A0-4F21-9CA5-4B264F011818

P407

Q35168298-C4561FD7-73B9-4846-9139-6450F40E5A64

P433

Q35168298-CE6EF625-60E0-4E91-BBF5-6FBCE45BB2FD

P478

Q35168298-8ED6A6F6-BB30-4DCA-ADF1-32A8CEAE0E5E

P50

Q35168298-D44B7561-4F4C-4F3A-86C2-201B10C86B01

P577

Q35168298-F51C2B3F-D445-449C-AE27-015E66C7B7A1

P698

Q35168298-AF3B5572-DF20-45A7-AB8F-217D8473990D

P932

Q35168298-2EE41E4A-DBD9-41AD-8B0C-2E5A20081135

P356

J.JURO.2009.07.013

P1433

The Journal of Urology

P1476

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate

@en

P2093

Daniel J Culkin

http://www.w3.org/2001/XMLSchema#string

David A Buethe

http://www.w3.org/2001/XMLSchema#string

John Califano

http://www.w3.org/2001/XMLSchema#string

Paul J Hauser

http://www.w3.org/2001/XMLSchema#string

Troy M Sofinowski

http://www.w3.org/2001/XMLSchema#string

P2860

Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder.

Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability

Hyaluronan catabolism: a new metabolic pathway.

Bladder surface glycosaminoglycans: an epithelial permeability barrier.

The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis.

New theories in interstitial cystitis.

Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis.

Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis

What is new in bladder pain syndrome/interstitial cystitis?

Rubidium efflux as a tool for the pharmacological characterisation of compounds with BK channel opening properties.

P304

2477-2482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2009.07.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

Robert E. Hurst

P577

2009-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19765766

http://www.w3.org/2001/XMLSchema#string

P932

3157297

http://www.w3.org/2001/XMLSchema#string